Skip to content

Study comparing effect of brihat and laghu gokhsura on high uric acid patients

Title - A Comparative pharmacognostical evaluation and clinical effectiveness of root powder of two varieties of Gokshura viz laghu and brihat on hyperurecemia. - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/113907
Enrollment
62
Registered
2026-07-14
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E790- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease

Interventions

None listed

Sponsors

Ravina
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Only confirmed diagnosed patient of hyperuricemia will be selected for the study range 7to 10mgdl patient who are willing to given written consent will be included both sex will be allowed and age group 21to 60

Exclusion criteria

Exclusion criteria: Female patient with pregnancy breastfeeding Post delivery period patient with some serious illness like CBD acute mental disorder serious acute organic disease patient with congenital renal abnormalities

Design outcomes

Primary

MeasureTime frame
The formulation selected for study powder formulation of root of laghu and brihat gokshura is effective in lowering the serum uric acidTimepoint: Baseline 30th day 60th day

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactRavina

MSM Institute of Ayurveda

nareshbhargav73@gmail.com9416051032

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026